- Researchers used computational analyses to evaluate the performance of 10 medications against the Omicron variant, finding that ivermectin outperformed all of them, including nirmatrelvir (Paxlovid) a new drug from Pfizer that has cost taxpayers $5.29 billion and costs $529 per course of treatment
- Ivermectin lowers the viral load by inhibiting replication, reduces infection by 86% when used preventively, speeds recovery, protects against organ damage, lowers the risk of hospitalization and death and costs between $48 and $95 for a course of treatment depending on your location
- Early treatment lowers your risk of long COVID, which includes physical and mental health conditions. According to cardiologist Dr. Peter McCullough, 50% of those sick enough to be hospitalized have symptoms of long COVID
- Africa has a lower number of cases, severity of disease, hospitalizations and deaths than other areas of the world, which may be due to using prophylactic medications for endemic infections that have successfully treated COVID
https://articles.mercola.com/sites/articles/archive/2022/02/14/ivermectin-outperforms-other-medications.aspx?ui=3222fdd6bce5dd6aedab8e3146bd649d967923f5dad96dc0aa53ca74a23ad8e3&sd=20140916&cid_source=dnl&cid_medium=email&cid_content=art2HL&cid=20220214&mid=DM1108841&rid=1407164044
- Forums
- Science & Medicine
- New Study Confirms Ivermectin Outperforms Other Options
New Study Confirms Ivermectin Outperforms Other Options
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online